🇺🇸 FDA
Patent

US 9498471

Use of CDK9 inhibitors to reduce cartilage degradation

granted A61KA61K31/453A61K31/713

Quick answer

US patent 9498471 (Use of CDK9 inhibitors to reduce cartilage degradation) held by The Regents of the University of California expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/453, A61K31/713, A61K9/0019, A61P